NCBiotech News

Fertilizer usually means promoting growth of crops. However, Jack Odle, Ph.D., is studying how feeding prebiotics (indigestible fiber parts of foods) to piglets fertilizes the “good” bacteria in their guts and improves their health while also informing nutrition practices for human newborns.

Q2 Solutions, a Morrisville clinical trial laboratory services provider, announced plans today for a new $73 million precision medicine facility in Durham that is expected to create 749 jobs over seven years.

Vestaron, a start-up that recently moved its corporate headquarters to RTP from Kalamazoo, is moving to commercialize the use of bee-safe peptide-based bioinsecticides.

An NCBiotech-sponsored event at ECU called “Capture 180” lets undergraduate students doing mentored research describe their projects in three minutes or less, using one visual aid. No pressure.

Merz announced plans this week to reorganize into three independently operating businesses and Raleigh will be the official global headquarters of the medical aesthetics unit, under CEO Bob Rhatigan.

SQZ Biotechnologies' tolerizing antigen carriers may help expand patient eligibility for AskBio's gene therapies.

Triangle Business Journal released the annual list of the Triangle’s 50 fastest-growing companies, and five life science companies made the cut.

Raybow Pharmaceutical acquires PhamAgra Labs, a custom R&D company in Brevard, and plans to triple the number of employees in the next several years.

The FDA has approved Raleigh-based RedHill Biopharma’s new drug to treat serious gastrointestinal infections after a priority review of the medication.

BioAgilytix, a Durham-based provider of large-molecule bioanalytical testing services, has acquired Cambridge Biomedical, a contract research organization based in the Boston suburb of Cambridge.

A unique, non-invasive urine test to diagnose cancers in dogs will soon get more “legs” in the marketplace, thanks to a deal struck by its developer, Raleigh-based Sentinel Biomedical.

The recently expanding Novo Nordisk drug-manufacturing operations in Durham and Clayton will provide U.S. supplies of the company’s new diabetes drug Rybelsus.

Satsuma Pharmaceuticals, a South San Francisco pharmaceutical company with operations in Research Triangle Park, will use proceeds from a September $90.8 million initial public offering to develop its fast-acting, easy-to-use nasal powder inhaler formulation to treat migraine from pocket or purse.

Point Motion, a new Winston-Salem digital health company founded by a jazz musician, is using the music of movement to detect and monitor changes in wellbeing.

The North Carolina Biotechnology Center has launched a demonstration pilot program of free genetic testing for its employees in a collaboration with health technology company Color Genomics.